Researchers have developed a novel approach combining hydrogen-deuterium exchange mass spectrometry (HDX-MS) with computational methods, including artificial intelligence, to better study protein-protein interactions. The technique is designed to enhance understanding of these critical biological processes during preclinical drug development phases.
The method integrates HDX-MS technology with sandwich ELISA assays, creating a more comprehensive analytical framework. According to the research, this combination could provide deeper insights into how proteins interact at the molecular level, which is crucial for drug discovery and development processes.